AU2007340834B2 - Foxp3 peptide vaccine - Google Patents

Foxp3 peptide vaccine Download PDF

Info

Publication number
AU2007340834B2
AU2007340834B2 AU2007340834A AU2007340834A AU2007340834B2 AU 2007340834 B2 AU2007340834 B2 AU 2007340834B2 AU 2007340834 A AU2007340834 A AU 2007340834A AU 2007340834 A AU2007340834 A AU 2007340834A AU 2007340834 B2 AU2007340834 B2 AU 2007340834B2
Authority
AU
Australia
Prior art keywords
peptide
foxp3
seq
peptides
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007340834A
Other languages
English (en)
Other versions
AU2007340834A1 (en
Inventor
Ryuji Osawa
Takuya Tsunoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncotherapy Science Inc
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of AU2007340834A1 publication Critical patent/AU2007340834A1/en
Application granted granted Critical
Publication of AU2007340834B2 publication Critical patent/AU2007340834B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2007340834A 2007-01-03 2007-12-26 Foxp3 peptide vaccine Ceased AU2007340834B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US87861507P 2007-01-03 2007-01-03
US60/878,615 2007-01-03
US89647207P 2007-03-22 2007-03-22
US60/896,472 2007-03-22
PCT/JP2007/001466 WO2008081581A1 (en) 2007-01-03 2007-12-26 Foxp3 peptide vaccine

Publications (2)

Publication Number Publication Date
AU2007340834A1 AU2007340834A1 (en) 2008-07-10
AU2007340834B2 true AU2007340834B2 (en) 2013-02-28

Family

ID=39588270

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007340834A Ceased AU2007340834B2 (en) 2007-01-03 2007-12-26 Foxp3 peptide vaccine

Country Status (14)

Country Link
US (1) US8563516B2 (enExample)
EP (2) EP2114987A4 (enExample)
JP (1) JP5339375B2 (enExample)
KR (1) KR20090099075A (enExample)
CN (1) CN101641369B (enExample)
AU (1) AU2007340834B2 (enExample)
BR (1) BRPI0720794A2 (enExample)
CA (1) CA2674365A1 (enExample)
IL (1) IL199622A0 (enExample)
MX (1) MX2009007261A (enExample)
RU (1) RU2473557C2 (enExample)
SG (1) SG177199A1 (enExample)
TW (1) TWI441648B (enExample)
WO (1) WO2008081581A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009050486A2 (en) * 2007-10-19 2009-04-23 The University Of Surrey Peptide manipulators of regulatory t cell activity
CZ301144B6 (cs) * 2008-09-15 2009-11-18 Vysoká škola chemicko technologická v Praze Príprava monoklonálních protilátek proti FoxP3 proteinu s použitím modifikovaných virum podobných cástic Masonova-Pfizerova opicího viru
US8735361B2 (en) * 2008-12-24 2014-05-27 Oncotherapy Science, Inc. C1ORF59 peptides and vaccines including the same
TWI507204B (zh) * 2009-05-26 2015-11-11 Oncotherapy Science Inc Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
CA2842887C (en) * 2011-08-12 2021-01-19 Oncotherapy Science, Inc. Mphosph1 peptides and vaccines including the same
CN102603892B (zh) * 2012-02-22 2013-10-30 尉军 一种肿瘤标志物foxp3抗原多肽及应用
WO2017124001A2 (en) 2016-01-14 2017-07-20 Memorial Sloan-Kettering Cancer Center T cell receptor-like antibodies specific for foxp3-derived peptides
CN111375055B (zh) * 2020-02-20 2021-09-03 陈宛莎 一种2019-nCoV亚单位疫苗组合物及其免疫方法
WO2025136809A2 (en) * 2023-12-19 2025-06-26 Regeneron Pharmaceuticals, Inc. Foxp3 peptides and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006013336A1 (en) * 2004-08-05 2006-02-09 Univeersity College Cardiff Consultants Limited Hpv vaccine comprising peptides from host cell proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69225710T3 (de) * 1991-07-25 2004-10-14 Idec Pharmaceuticals Corp., San Diego Anregung von antworten zytotoxischer t-lymphozyten
JP4353701B2 (ja) * 2001-05-08 2009-10-28 ダーウィン モレキュラー コーポレイション Ｆｏｘｐ３蛋白質を用いた霊長類における免疫機能の調節方法
CN103073620B (zh) 2002-09-12 2014-12-10 肿瘤疗法科学股份有限公司 Kdr肽和包括该肽的疫苗
JP4628208B2 (ja) * 2004-08-10 2011-02-09 オンコセラピー・サイエンス株式会社 Ｃｘａｄｒｌ１またはｇｃｕｄ１タンパク質を発現する胃癌または結腸直腸癌の治療のためのペプチドワクチン
WO2006077941A1 (ja) 2005-01-19 2006-07-27 Keio University 癌ワクチン

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006013336A1 (en) * 2004-08-05 2006-02-09 Univeersity College Cardiff Consultants Limited Hpv vaccine comprising peptides from host cell proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Nair et al. (2007) Cancer Research 67 (1): 371-380 *

Also Published As

Publication number Publication date
CA2674365A1 (en) 2008-07-10
KR20090099075A (ko) 2009-09-21
BRPI0720794A2 (pt) 2014-03-11
JP5339375B2 (ja) 2013-11-13
MX2009007261A (es) 2009-11-11
SG177199A1 (en) 2012-01-30
TWI441648B (zh) 2014-06-21
CN101641369B (zh) 2014-10-22
RU2473557C2 (ru) 2013-01-27
TW200835516A (en) 2008-09-01
EP2481748A2 (en) 2012-08-01
JP2010514669A (ja) 2010-05-06
CN101641369A (zh) 2010-02-03
RU2009129531A (ru) 2011-02-10
US8563516B2 (en) 2013-10-22
AU2007340834A1 (en) 2008-07-10
EP2481748A3 (en) 2012-10-24
WO2008081581A1 (en) 2008-07-10
EP2114987A1 (en) 2009-11-11
IL199622A0 (en) 2010-04-15
EP2114987A4 (en) 2010-07-21
US20100092501A1 (en) 2010-04-15

Similar Documents

Publication Publication Date Title
US8367799B2 (en) TEM8 peptides and vaccines comprising the same
AU2009261382B2 (en) CDCA1 epitope peptides and vaccines containing the same
AU2009283762A1 (en) INHBB epitope peptides and vaccines containing the same
AU2007340834B2 (en) Foxp3 peptide vaccine
AU2009258775B2 (en) MYBL2 epitope peptides and vaccines containing the same
US20110200626A1 (en) Iqgap3 epitope peptides and vaccines containing the same
AU2009277811B2 (en) MELK epitope peptides and vaccines containing the same
US9745343B2 (en) Method of inducing an immune response by administering WDRPUH epitope peptides
AU2008238739B2 (en) TEM8 peptides and vaccines comprising the same
HK1174337A (en) Foxp3 peptide vaccine
HK1175197B (en) Tem8 peptides and vaccines comprising the same

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired